Ashish Pemawat: The INSTANT Trial Opens New Questions in Acute Stroke Therapy
Ashish Pemawat, Associate Director of Institute of Neurosciences, shared on LinkedIn about a recent article by INSTANT Trial Authors, published in JAMA, adding:
”Can adjunctive tirofiban improve outcomes after intravenous thrombolysis? The INSTANT Trial offers an intriguing perspective.
The recently published INSTANT Trial in JAMA evaluated intravenous tirofiban after tenecteplase in patients with acute ischemic stroke who had no large- or medium-vessel occlusion and no cardioembolic source.
The study demonstrated a higher rate of excellent functional outcomes at 90 days with tirofiban (mRS 0–1: 63.8% vs. 52.2%) without a significant increase in serious safety events.
While these findings are not yet practice-changing, they introduce an exciting concept: can adjunctive antiplatelet therapy enhance reperfusion in selected patients who are not candidates for thrombectomy?
The INSTANT trial is an important step toward refining acute stroke therapy beyond recanalization alone.”
Title: Intravenous Tirofiban After Tenecteplase in Acute Ischemic Stroke: The INSTANT Randomized Clinical Trial
Authors: INSTANT Trial Authors for the INSTANT Investigators
Stay updated on all scientific advances with Hemostasis Today.
-
Oct 20, 2026, 06:45Grant Garcia: Why Does a Blood Clot Diagnosis Immediately End an Athlete’s Season?
-
Oct 20, 2026, 06:35Parag Tamhankar: Landmark Study Reveals Genetic Spectrum and Targeted Therapies for ALPS in the Indian Population
-
Oct 20, 2026, 06:26Nina Houben: Neonatal Blood Transfusion Symposium and PhD Defense
-
Oct 20, 2026, 05:46Jan T. Kielstein: DNP Poisoning and Hemoadsorption The Limits of Rescue Therapy
-
Oct 20, 2026, 05:33Giulia Di Paolo: Connecting Plasma Donation to the Patients Who Depend on It
-
Oct 20, 2026, 05:20James Knowles: Exploring Plasma Manufacturing and Strengthening Industry Collaboration
-
Oct 20, 2026, 05:11Giuseppe Lippi։ Understanding Liver Test Abnormalities After AAV Gene Therapy
-
Oct 20, 2026, 05:02Sanam Loghavi: Test Your Hematology Knowledge at ASH 2026!
-
Oct 20, 2026, 04:13Ifeanyichukwu Ifechidere: DOACs Are Not the Answer to Every Anticoagulation Question